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We present a seminested PCR method that specifically discriminates between Plasmodium ovale curtisi and P. ovale wallikeri
with high sensitivity. The test is based on species-specific amplification of a size-polymorphic fragment of the tryptophan-rich
antigen gene, potra, which also permits discrimination of intraspecific sequence variants at this locus.
Plasmodium ovale has long been considered a parasite that ispredominantly found in Tropical Africa, most often in West
Africa, and in some islands in the Western Pacific (1). Confirmed
cases have occasionally been reported fromother regions in which
the parasite is endemic, except for theAmericas (2, 3). Four factors
have contributed to the perception that this species is relatively
rare. The clinical course is short and comparativelymild (there are
very few records of severity or mortality), the parasite burdens are
generally low (peak parasitemias rarely exceed 25,000 parasites per
l of blood in naive individuals), the species is oftenmisdiagnosed
in areas where P. ovale is not known to be endemic, and finally,
accurate diagnosis bymicroscopy examination, especially of thick
smears, is difficult (2). The last two obstacles were circumvented
by the introduction of sensitive molecular techniques (4). These
provided the first indication that the prevalence and geographic
range of P. ovale were likely to have been underestimated (5).
Molecular-based detection also revealed a dimorphism in the P.
ovale A-type small subunit rRNA (ssrRNA) genes (6, 7), which
extended to other genes (8). Multilocus sequence analysis of iso-
lates fromdiverse geographical origins culminated in the proposal
that there were actually two species, P. ovale curtisi (classic type)
and P. ovale wallikeri (variant type) (9). These two species are
globally distributed and sympatric (6, 9–14).
In the context of a long-term goal to achieve malaria elimina-
tion, it becomes important to understand the epidemiology of P.
ovale, a species which is more widespread than previously under-
stood andwhich shares withP. vivax the formation of hypnozoites
that cause relapses (15, 16). Recent observations suggest that the
species might differ in their relapse patterns (17). Given the gen-
erally low parasite burdens, future investigations must incorpo-
rate molecular methods for sensitive detection and identification
of the two species, as well as a means to discriminate between
different strains using polymorphic markers. A number of proto-
cols based on the ssrRNA genes (10, 12, 18) are suitable for iden-
tification but not for genotyping. Sequence and size variations
were noted between the tryptophan-rich antigen genes (poctra
and powtra) from P. ovale curtisi and P. ovale wallikeri (9). This
was exploited in a nested PCR detection assay (11), where primers
target sequences conserved between these two genes and the spe-
cies are discriminated by the size of the amplified fragments (299
bp or 317 bp for poctra; 245 bp for powtra). The amplified frag-
ment size variations result from differences in the number of re-
peated units, which suggests that a broader spectrum of size vari-
ants, possibly overlapping for P. ovale curtisi and P. ovale wallikeri,
respectively, might occur. This would invalidate amplified frag-
ment size difference as a means of distinguishing between P. ovale
curtisi and P. ovale wallikeri.
When a set of P. ovale isolates collected from Thailand (n 9;
T series) and Vietnam (n  2; V series) were tested using the
species-conserved potra oligonucleotides (11), a broader range of
fragment sizes than that noted previously (11) was observed, with
some overlap between the two species (Table 1). Consequently, we
designed a new set of primers suitable for species-specific semi-
nested PCR. The oligonucleotide primers were designed based on
the potra gene sequences available in GenBank (accession no.
HM594182 to HM594183 for P. ovale curtisi, accession no.
HM594180 to HM594181 for P. ovale wallikeri). For the primary
reaction, a fragment of ca. 705 bp spanning the repeat region of
poctra and powtra was amplified using oligonucleotides targeting
regions conserved between the two species by using a new primer,
PoTRA-F (5=-CATTTTACGTAGGCATCTAA-3=), which targets
the 5= end of the gene, and the previously published PoTRA rev3
(11). For the secondary amplification reaction, PoTRA-Fwas used
in two separate reactions, but in this case with an oligonucleotide
specific to each of the two species, either PocTRA-R (5=-TTTATG
GATGGTGTGACTGTTGTATCTATA-3=) or PowTRA-R (5=-TG
TGTGGTTGGTTTGACTATCGTATCTAAG-3=) was used for P.
ovale curtisi and P. ovale wallikeri, respectively (Fig. 1). The ampli-
fication conditions for the primary reaction were optimized by
using genomic DNA isolated from P. ovale curtisi (T13)- or P.
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ovale wallikeri (TVZ1)-infected blood samples (with respect to
annealing temperature as well as Mg2 and oligonucleotide con-
centrations). The fragments obtained for each species were then
cloned into the pCR 2.1 vector (Invitrogen, USA), and each plas-
mid was purified from the bacterial clones. These standard plas-
mids were used to optimize the conditions for the secondary am-
plification reactions (with respect to annealing temperature as
well as Mg2 and oligonucleotide concentrations) and to derive
the limit of detection of the seminested PCR protocol. The con-
centration of each standard plasmid stock solution was deter-
mined by using the optical density of the solution at 260 nm. The
copy number of each standard plasmid perl was calculated as the
mass of the plasmid standard (g/l) divided by the calculatedmass
of each molecule (number of bp  660 g/6.027  1023). A serial
dilution series, in which there were 1, 2, 5, 10, 102, 103, 104, or 105
copies per l, was then obtained, and 1 l of each dilution was
tested five times.
All reactions were carried out in a total volume of 20 l in the
presence of 10mMTris-HCl (pH 8.3), 50 mMKCl, 75 or 125M
for each deoxyribonucleotide triphosphate, and 0.4 units of Taq
polymerase (Invitrogen, USA). The primary amplification was
carried out at a final concentration of 2mMMgCl2 and 75 nM for
each primer, with an annealing temperature of 56°C, whereas the
secondary amplification was carried out using an annealing tem-
perature of 60°C, with a final concentration of 3 mM for MgCl2
and 125 nM for each primer. One microliter of template was used
to initiate both the primary and secondary amplification reac-
tions. The cycling parameters consisted of an initial denaturation
step at 95°C for 5 min, annealing for 1 min, and then extension at
72°C for 1min, followed by a denaturation step at 94°C for 1min.
After a given number of cycles (25 cycles for the primary amplifi-
cation and 30 cycles for the secondary amplification), a final ex-
tension step at 72°C was carried out before storage of the product
at 4°C. Ten microliters of the secondary reaction products was
electrophoresed on a 2% agarose gel, and the bands were then
visualized by UV transillumination, following staining with
ethidium bromide.
The limit of detection, as based on the template with a known
number of plasmid molecules, was five copies, for which all five
duplicates gave a positive result. The specificity of the reactionwas
confirmed by using high concentrations of genomic DNA (equiv-
alent to 104 parasite genomes) from P. falciparum, P. vivax, P.
malariae, or human DNA as templates alone (all reactions proved
negative) or mixed with one or other of the standard plasmid
templates that demonstrated that sensitivity was not affected. No
detectable fragments could be amplified when plasmid DNA car-
rying the potra fragment from one P. ovale species was used as a
template for the secondary amplification reaction, in which the
primer pair specific for the potra of the other P. ovale species was
used. The sensitivity and specificity of the protocol was then as-
sessed by using genomic DNA purified from clinical blood sam-
ples containing P. ovale curtisi and P. ovale wallikeri that had been
enumerated accurately (416 parasites/l blood and 1,152 para-
sites/l blood). These genomic DNAs were then serially diluted
and assayed. The seminested protocol was able to consistently
detect a parasitemia equivalent to 2 to 10 parasites/l blood. The
specificity and the consistency of the sensitivity were again con-
firmed by adding excess P. falciparum, P. vivax, P. malariae, or
human genomic DNAs to the serially diluted DNA. Finally,
genomic DNA templates from 30 patients infected with P. falcip-
arum (n 10), P. vivax (n 10), or P.malariae (n 10) were also
tested and proved negative.
The seminested PCR protocol was then applied to DNA puri-
fied from 17 clinical blood samples: 7 samples infected with P.
ovale curtisi (two of these were mixed infections with P. falcipa-
TABLE 1 Sizes of the sequenced potra fragments amplified using the
different primer pairs
Sample(s)
P. ovale
subspecies
Potra fwd5
Potra rev5
(bp)
PoTRA-F
PocTRA-R
(bp)
PoTRA-F
PowTRA-R
(bp)
POW1 or POW2a wallikeri 245 389
11 (Africa) wallikeri 245 389
T7, T9, T11, T19b wallikeri 299 443
T22 (P. vivax) wallikeri 299 443
T12 (P. falciparum) wallikeri 299 443
VP, TVZ1c wallikeri 335 479
POC1d curtisi 299 443
VN, T14e curtisi 299 443
POC2d curtisi 317 461
T13f curtisi 353 497
a POW1 and POW2 sequences were previously obtained (GenBank accession no.
HM594180 and HM594181, respectively).
b GenBank accession no. for T19 is KF018430.
c GenBank accession no. for TVZ1 is KF018431.
d POC1 and POC2 sequences were previously obtained (GenBank accession no.
HM594182 and HM594183, respectively).
e GenBank accession no. for T14 is KF018433.
f GenBank accession no. for T13 is KF018432.
FIG 1 Predicted amino acid alignment of the distinct potra fragments amplified from P. ovale curtisi and P. ovale wallikeri. Boxed sequences represent the
repetitive regions thatwere seen to vary in length between isolates. Shaded residues indicate those that appear to be specific toP. ovalewallikeri genes. Black arrows
indicate the positions of the oligonucleotides used in the secondary amplification reaction to generate the size variants observed for poctra and powtra: at the 5=
end, the PoTRA-F primerwhose target includes the 12 bp preceding the open reading frame recognizes the gene fromboth species, while two 3=-end primerswere
designed to specifically recognize the poctra or powtra gene.
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rum) and 10 samples infected with P. ovale wallikeri (two of these
were mixed infections, one with P. falciparum and the other with
P. vivax). The species present in these samples had been previously
established by analysis of the ssrRNA genes and themitochondrial
locus pocytb (9). The potra-based protocol presented here cor-
rectly identified the species present in each sample. Moreover, the
isolates from each species could be classed according to the am-
plified fragment size. Three distinct allelic potra variants were se-
quenced for each species, and the predicted amino acid sequences
were aligned (Fig. 1). Subsequent to this, two potentially new size
variants were amplified (Fig. 2) from a P. ovale curtisi sample re-
cently collected from a patient who had acquired the infection in
Africa (the exact country had not been recorded).
Thus, we present a sensitive seminested PCR protocol that not
only allows discrimination between P. ovale curtisi and P. ovale
wallikeri with high specificity but also provides a simple means to
identify genotypic variants within each of these species. We are
aware that nested PCR protocols are associated with two disad-
vantages. The first is the additional cost and labor of carrying out
an additional PCR. The second is the substantially increased risk
of contamination inherent to the transfer of the PCR product
from the first to the second reaction; in our experience, this risk
can be substantially reduced by the allocation of a distinct labora-
tory space for this transfer. We feel that in this particular case, the
use of a seminested PCR protocol can be justified. The limit of
detection of nested PCR-based protocols is often higher than that
of methods based on a single amplification step, an important
consideration for P. ovale infections where parasite burdens are
often quite low. Moreover, the nested PCR format is less sensitive
to inhibitors present in the initial template. Finally, discrimina-
tion of allelic variants by size is most practically carried out fol-
lowing gel electrophoresis, a step that will negate any advantage of
methods where the amplified product remains in closed tubes.
Ultimately, the protocol presented here is intended for fundamen-
tal investigations on the two P. ovale species and not for imple-
mentation in a routine laboratory, as there is no evidence that the
clinical course or the treatment required varies between P. ovale
wallikeri and P. ovale curtisi infections.
As more samples are analyzed, it is likely that the number of
potra size variants that occur would exceed those observed to date
(five for poctra and three for powtra). In conclusion, the potra
genes could now serve as targets for molecular identification and
as genetic markers suitable for a broad range of investigations of
the epidemiology and biology of P. ovale curtisi and P. ovale wal-
likeri, similar to those carried out for P. falciparum and P. vivax
(19–21).
Nucleotide sequence accession numbers. The potra gene se-
quences for samples T19, TVZ1, T13, and T14 were deposited in
GenBank under accession numbers KF018430 to KF018433, re-
spectively.
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